Reduction in diagnostic and therapeutic interventions by non-invasive determination of fetal sex in early pregnancy
The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: This study reviews our clinical experience of non-invasive techniques for early sex determination. It assesses the effectiveness of these techniques at reducing invasive prenatal testing for X-linked genetic disease or for ambiguous development of the external genitalia. METHODS: A prospective cohort study of 30 pregnancies was referred to a tertiary unit for prenatal diagnosis. Fetal gender was determined using two non-invasive techniques: analysis of free fetal DNA (ffDNA) in maternal plasma and ultrasound visualisation. The results were compared to fetal gender determined by invasive testing or at birth. RESULTS: Fetal gender was accurately determined by analysis of ffDNA at a mean of 10 + 1 (7 + 6 to 14 + 1) weeks' gestation in all cases. Ultrasound assessment was accurate in 20 of the 23 cases where this was attempted at 12 + 0 (10 + 4 to 14 + 1) weeks' gestation, but could not be determined in the remaining 3 cases. Thirteen of 28 (46%) women chose not to have invasive testing on the basis of these findings. CONCLUSIONS: Both the techniques appear to offer an accurate means of assessing fetal gender, giving parents the option of avoiding invasive testing in the 50% of cases where the fetus would not be affected. The molecular technique is performed at an earlier gestation, but female fetal status is predicted by a negative test result. Ultrasound cannot be applied until 11 weeks' gestation but diagnostic signs are sought in both sexes. Combining these approaches offers a highly sensitive method of non-invasive determination of gender in high-risk pregnancies. Health professionals, clinical geneticists and genetics associates, in particular, who refer women at high risk should be aware of these non-invasive options for prenatal sex determination.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Presence of fetal DNA in maternal plasma and serum
Lo, Y. M. D., Corbetta, N., Chamberlain, P. F., Rai, V., Sargent, I. L., Redman, C. W., & Wainscoat, J. S. (1997) · The Lancet · doi:10.1016/s0140-6736(97)02174-0 · Cited by 3,129
Joint LWPES/ESPE CAH Working Group (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-020611 · Cited by 332
Fetal phallic growth and penile standards for newborn male infants
Feldman, K. W., & Smith, D. W. (1975) · The Journal of Pediatrics · doi:10.1016/s0022-3476(75)80969-3 · Cited by 308
Long-Term Somatic Follow-Up of Prenatally Treated Children with Congenital Adrenal Hyperplasia1
Lajic, S., Wedell, A., Bui, T.-H., Ritzén, E. M., & Holst, M. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.11.5233 · Cited by 164 · cited 2×
“…before 9 weeks’ gestation prevents virilisation, many of our patients are unwilling to take steroids because of the theoretical risk of side effects and the fact that seven out of eight pregnancies that are treated will be unaffected (Lajic et al., 1998; Joint LWPES/ESPE CAH Working Group, 2002).”
BackgroundFetal DNA in maternal plasma: biology and diagnostic applications
Lo, Y. M. D. (2000) · Clinical Chemistry · doi:10.1093/clinchem/46.12.1903 · Cited by 142
Cited by
Liquid biopsies come of age: Towards implementation of circulating tumour DNA
Wan, J. C. M., Massie, C., Garcia-Corbacho, J., Mouliere, F., Brenton, J. D., Caldas, C., Pacey, S., Baird, R., & Rosenfeld, N. (2017) · Nature Reviews Cancer · doi:10.1038/nrc.2017.7 · Cited by 2,809
Mackie, F., Hemming, K., Allen, S., Morris, R., & Kilby, M. (2017) · BJOG: An International Journal of Obstetrics & Gynaecology · doi:10.1111/1471-0528.14050 · Cited by 292
Noninvasive Fetal Sex Determination Using Cell-Free Fetal DNA: A Systematic Review and Meta-analysis
Devaney, S. A., Palomaki, G. E., Scott, J. A., & Bianchi, D. W. (2011) · JAMA · doi:10.1001/jama.2011.1114 · Cited by 247
Non-invasive prenatal determination of fetal sex: translating research into clinical practice
Hill, M., Finning, K., Martin, P., Hogg, J., Meaney, C., Norbury, G., Daniels, G., & Chitty, L. (2011) · Clinical Genetics · doi:10.1111/j.1399-0004.2010.01533.x · Cited by 168
“This is consistent with previous reports of cffDNA sex determination for pregnancies at risk of X-linked disorders, where most women carrying female fetuses chose to avoid CVS, while the majority carrying male fetuses underwent invasive testing as there is still a need to confirm if the fetus had inherited the mutant…”
ResultSelf-citation
Metadata
- Authors
- Hyett, J. A., Gardener, G., Stojilkovic-Mikic, T., Finning, K. M., Martin, P. G., Rodeck, C. H., & Chitty, L. S.
- Venue
- Prenatal Diagnosis
- Publisher
- Wiley
- Published
- 2005
- Volume
- 25
- Issue
- 12
- Pages
- 1111-1116
- ISSN
- 0197-3851 (ISSN-L)
- 1097-0223
- OpenAlex
- W2153600510
- Cited by
- 110
- References
- 5
- FWCI
- 4.49
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Reduction in diagnostic and therapeutic interventions by non-invasive determination of fetal sex in early pregnancy. https://app.cochat.ai/papers/10.1002/pd.1284
- The paper
- Hyett, J. A., Gardener, G., Stojilkovic-Mikic, T., Finning, K. M., Martin, P. G., Rodeck, C. H., & Chitty, L. S. (2005). Reduction in diagnostic and therapeutic interventions by non-invasive determination of fetal sex in early pregnancy. Prenatal Diagnosis. https://doi.org/10.1002/pd.1284
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.